Fulcrum Therapeutics (FULC) PT Lowered to $14 at Oppenheimer
Tweet
Share
E-mailGet Alerts FULC Hot Sheet
Price: $3.80 +5.26%
Rating Summary:
4 Buy, 7 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
4 Buy, 7 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Oppenheimer analyst Matthew Biegler lowered the price target on Fulcrum Therapeutics (NASDAQ: FULC) to $14.00 (from $16.00) while maintaining a Outperform rating.
You May Also Be Interested In
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,455 at Citi
- Hemlo Mining (HMMC:CN) PT Raised to Cdn$10 at Scotiabank
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR1,965 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
